COMBO dual-therapy stent: non-inferior to drug-eluting stents or stepping back to bare metal stents?

Affiliations

¹ Division of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
² Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, Japan.

Comment

Kyohei Yamaji et al. Eur Heart J. 2018.

. 2018 Jul 7;39(26):2469-2471.

doi: 10.1093/eurheartj/ehy351.

¹ Division of Cardiology, Kokura Memorial Hospital, Kitakyushu, Japan.
² Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto, Japan.

No abstract available

Comment on

Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome.
Saito S, Krucoff MW, Nakamura S, Mehran R, Maehara A, Al-Khalidi HR, Rowland SM, Tasissa G, Morrell D, Joseph D, Okaniwa Y, Shibata Y, Bertolet BD, Rothenberg MD, Généreux P, Bezerra H, Kong DF. Saito S, et al. Eur Heart J. 2018 Jul 7;39(26):2460-2468. doi: 10.1093/eurheartj/ehy275. Eur Heart J. 2018. PMID: 29931092 Free PMC article. Clinical Trial.